All In Biotech

Drug Trial Radar · NCT04398823

A Multicenter Prospective Clinical Study of Endoscopic Foam Sclerotherapy for Internal Hemorrhoids

Last checked: Nov 20, 2026Latest source record: May 21, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 700 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

700

Planned (sponsor's estimate)

Start

May 15, 2020

Primary completion

Dec 31, 2020

Study completion Dec 31, 2021

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Shanghai Tong Ren Hospital; Shanghai Construction Group Hospital; Shandong Maternal and Chidl Care Service Center; Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University; West China Fourth Hospital; The First Affiliated Hospital of Anhui Medical University; The First Affiliated Hospital of Zhengzhou University; Jiangsu Provincial Second Chinese Medicine Hospital; Anhui Provincial Hospital; Luoyang Central Hospital; Ganzhou Fifth pepole's Hospital; Changzhi People's Hospital; Nanjing PLA General Hospital
First posted
May 21, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

"Internal hemorrhoid" affects the quality of life due to hemorrhage and prolapse as a common and frequently-occurring disease. Endoscopic sclerosing agent injection has replaced traditional surgery and become the most commonly used treatment method in developed countries. At present, how to reduce the side effects of sclerosing agent and accurately determine the injection site and depth has become a difficult clinical problem. The research group creatively put forward the theory of foam sclerosing agent to treat internal hemorrhoids in the early stage. With the aid of transparent cap, the visibility of surgical field of vision can be improved. The mini probe ultrasound (MPS) is proposed to effectively evaluate the submucosal in

Conditions

  • Grade/Stage I Hemorrhoids
  • Prolapsed Grade II Internal Haemorrhoid
  • Prolapsed Grade III Internal Haemorrhoid

Interventions

  • Sclerosing foam of LauromacrogolDrug

    Participants in FS will receive enteroscopy with the sclerosing foam of lauromacrogol.

  • Sclersing liqiud of LauromacrogolDrug

    Participants in LS will receive enteroscopy with the sclerosing liquid of lauromacrogol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. the condition of bleeding、perianal pruritus 、the degree of prolapse of internal hemorrhoids and the influence of internal hemorrhoids by self-assessment.Time frame: 12 months
  2. the condition of perianal pruritus、the description of hemorrhoids(include the number and depth of hemorrhoids)、the need for additiongal sclerotherapy under colonic endoscopy.Time frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Xinhua Hospital,Shangha Jiao Tong University

    Shanghai, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.